344 related articles for article (PubMed ID: 18327705)
1. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
[TBL] [Abstract][Full Text] [Related]
4. Use of erythropoietin for cardiovascular protection.
Bahlmann FH
Cardiovasc Drugs Ther; 2008 Aug; 22(4):253-5. PubMed ID: 18500549
[No Abstract] [Full Text] [Related]
5. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
Cheng Y; Hu R; Lv L; Ling L; Jiang S
J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
8. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
Lipsic E; Westenbrink BD; van der Meer P; van der Harst P; Voors AA; van Veldhuisen DJ; Schoemaker RG; van Gilst WH
Eur J Heart Fail; 2008 Jan; 10(1):22-9. PubMed ID: 18077209
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
[TBL] [Abstract][Full Text] [Related]
10. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
[TBL] [Abstract][Full Text] [Related]
11. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9.
Iwakura A; Shastry S; Luedemann C; Hamada H; Kawamoto A; Kishore R; Zhu Y; Qin G; Silver M; Thorne T; Eaton L; Masuda H; Asahara T; Losordo DW
Circulation; 2006 Mar; 113(12):1605-14. PubMed ID: 16534014
[TBL] [Abstract][Full Text] [Related]
12. Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells.
Zeng R; Chen YC; Zeng Z; Liu WQ; Jiang XF; Liu R; Qiang O; Li X
Heart Vessels; 2011 Jan; 26(1):69-80. PubMed ID: 20963594
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid A promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells.
Li YJ; Duan CL; Liu JX
J Ethnopharmacol; 2014; 151(1):218-27. PubMed ID: 24189032
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.
Heeschen C; Aicher A; Lehmann R; Fichtlscherer S; Vasa M; Urbich C; Mildner-Rihm C; Martin H; Zeiher AM; Dimmeler S
Blood; 2003 Aug; 102(4):1340-6. PubMed ID: 12702503
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin protects against doxorubicin-induced heart failure.
Ammar HI; Saba S; Ammar RI; Elsayed LA; Ghaly WB; Dhingra S
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2413-21. PubMed ID: 21984540
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
Hirata A; Minamino T; Asanuma H; Fujita M; Wakeno M; Myoishi M; Tsukamoto O; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Shiraga M; Kitakaze M; Hori M
J Am Coll Cardiol; 2006 Jul; 48(1):176-84. PubMed ID: 16814664
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction.
Zhang D; Zhang F; Zhang Y; Gao X; Li C; Ma W; Cao K
Cardiology; 2007; 108(4):228-36. PubMed ID: 17106196
[TBL] [Abstract][Full Text] [Related]
19. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
Takeda Y; Uemura S; Iwama H; Imagawa K; Nishida T; Onoue K; Takemoto Y; Soeda T; Okayama S; Somekawa S; Ishigami K; Takaoka M; Kawata H; Kubo A; Horii M; Nakajima T; Saito Y
Circ J; 2009 Sep; 73(9):1674-82. PubMed ID: 19602778
[TBL] [Abstract][Full Text] [Related]
20. Effects of erythropoietin on angiogenesis after myocardial infarction in porcine.
Kawachi K; Iso Y; Sato T; Wakabayashi K; Kobayashi Y; Takeyama Y; Suzuki H
Heart Vessels; 2012 Jan; 27(1):79-88. PubMed ID: 22038108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
